Trials / Unknown
UnknownNCT05971901
A Combinatorial Biomarker for Infection Diagnosis in Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 770 (estimated)
- Sponsor
- Universität des Saarlandes · Academic / Other
- Sex
- All
- Age
- 5 Months
- Healthy volunteers
- Not accepted
Summary
To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement. Secondary objectives: * Qualitative evaluation of indication as well as adherence to the test result. * Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | BV | The use of the BV test, ordered at the discretion of the treating physician |
Timeline
- Start date
- 2023-02-24
- Primary completion
- 2024-10-01
- Completion
- 2024-11-01
- First posted
- 2023-08-02
- Last updated
- 2023-08-02
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05971901. Inclusion in this directory is not an endorsement.